Preferred Label : sotatercept;
UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T123 - Biologically Active Substance;
Is substance : O;
Origin ID : M0584008;
UMLS CUI : C2699571;
ATC code(s)
- Currated CISMeF NLP mapping
- Related record
- ACE-011 [MeSH Supplementary Concept]
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3508311/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
sotatercept
---
https://ansm.sante.fr/tableau-acces-derogatoire/sotatercept
2025
false
false
false
France
French
sotatercept
recombinant fusion proteins
Pulmonary Arterial Hypertension
guidelines for drug use
Pulmonary arterial hypertension WHO functional class III
Pulmonary arterial hypertension WHO functional class II
insurance, health, reimbursement
adult
sotatercept
summary of product characteristics
package leaflet
Pulmonary arterial hypertension WHO functional class IV
---
https://www.has-sante.fr/jcms/p_3658407/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire-htap
2025
France
evaluation of the transparency committee
Pulmonary Arterial Hypertension
sotatercept
pulmonary hypertension, nos
hypertensive disease, nos
---
https://www.ema.europa.eu/en/medicines/human/EPAR/winrevair
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
sotatercept
sotatercept
orphan drug production
sotatercept
hypertension, pulmonary
injections, subcutaneous
drug approval
europe
adult
drug therapy, combination
activins
risk management
pregnancy
breast feeding
aged
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3606289/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire-htap
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
drug therapy, combination
respiratory system agents
sotatercept
Pulmonary arterial hypertension WHO functional class II
Pulmonary arterial hypertension WHO functional class III
injections, subcutaneous
evaluation of the transparency committee
sotatercept
Pulmonary Arterial Hypertension
---
https://www.has-sante.fr/jcms/p_3508311/fr/sotatercept-sotatercept-hypertension-arterielle-pulmonaire
2024
false
false
false
France
ACE-011
adult
drug therapy, combination
Pulmonary arterial hypertension WHO functional class II
Pulmonary arterial hypertension WHO functional class III
guidelines for drug use
orphan drug production
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
sotatercept
---
